Home/Filings/4/0000950170-25-012530
4//SEC Filing

Caplan Jay David 4

Accession 0000950170-25-012530

CIK 0001572616other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:03 PM ET

Size

15.5 KB

Accession

0000950170-25-012530

Insider Transaction Report

Form 4
Period: 2025-01-30
Caplan Jay David
President, Chief Product Off.
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-31$1.70/sh+22,346$37,988175,890 total
  • Sale

    Common Stock

    2025-01-31$1.81/sh22,346$40,464153,544 total
  • Sale

    Common Stock

    2025-01-30$1.95/sh21,472$41,802153,544 total
  • Exercise/Conversion

    Stock Option

    2025-01-3021,47240,270 total
    Exercise: $1.70Exp: 2025-02-10Common Stock (21,472 underlying)
  • Exercise/Conversion

    Stock Option

    2025-01-3122,34617,924 total
    Exercise: $1.70Exp: 2025-02-10Common Stock (22,346 underlying)
  • Exercise/Conversion

    Common Stock

    2025-01-30$1.70/sh+21,472$36,502175,016 total
Holdings
  • Common Stock

    (indirect: By Trust)
    358,806
  • Common Stock

    (indirect: By Trust)
    118,810
Footnotes (4)
  • [F1]Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option is fully vested and exercisable.

Documents

1 file

Issuer

FRACTYL HEALTH, INC.

CIK 0001572616

Entity typeother

Related Parties

1
  • filerCIK 0001419217

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:03 PM ET
Size
15.5 KB